跳至主要内容
临床试验/RPCEC00000116
RPCEC00000116已完成2 期

Perioperative administration of probiotics in colorectal cancer patients operated by laparoscopy: A randomized double-blind trial.

ational Center for Minimal Access Surgery0 个研究点目标入组 166 人开始时间: 2011年5月19日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
166

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Other

入排标准

年龄范围
18 years 至 /A (Not limit)(—)
性别
All

入选标准

  • Patients with 18 years or older. • The diagnosis of colorectal cancer is confirmed by biopsy and histological test. • The preoperative disease stage is estimated as I, II or III, according to TNM classification. •The proposed surgical procedure is a laparoscopic radical resection.

排除标准

  • Pregnancy. • Preoperative evidence of far-away metastasis (disease stage IV, according to TNM classification) • Known lactose intolerance. • Clinically significant immunodeficiency. • Additional gastrointestinal disorders (e.g. Crohn’s disease or ulcerative colitis). • Patients received antibiotics for the last 10 days before surgery. • Patients undergone urgent operation (e.g. intestinal obstruction or bleeding). • Bowel preparation for colonoscopy within 6 days prior to surgery. • Patients refuse participate in the trial. • Patients undergone abdominoperineal resection of the rectum.

研究者

发起方
ational Center for Minimal Access Surgery

相似试验